ERYTECH PHARMA launches a subscription of BSPCE warrants reserved for its main executives admERY January 28, 2014 Newsroom ERYTECH launch a subscription of BSPCE reserved for its main executives. You Might Also Like ERYTECH establishes a financing facility with the implementation of an at-the-market program on Nasdaq with Cowen September 21, 2020 ERYTECH Reports Financial Highlights for Q4 2015 January 11, 2016 ERYTECH to Present Results from Phase I Trial of eryaspase in ALL and New Pre-clinical Data at AACR 2018 April 12, 2018
ERYTECH establishes a financing facility with the implementation of an at-the-market program on Nasdaq with Cowen September 21, 2020
ERYTECH to Present Results from Phase I Trial of eryaspase in ALL and New Pre-clinical Data at AACR 2018 April 12, 2018
